Keryx Biopharma (KERX) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Financial Fact:
Interest and other income, net: 150K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest and other income, net: 150K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Keryx Biopharma (NASDAQ: KERX) reported Q1 EPS of ($0.28), $0.02 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $2.45 million.
For earnings history and earnings-related data on Keryx Biopharma (KERX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
